US 9617596
Biomarkers predictive for clinical response for glatiramer acetate
granted A61PA61P25/00A61P25/02
Quick answer
US patent 9617596 (Biomarkers predictive for clinical response for glatiramer acetate) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/00, A61P25/02, A61P25/28